TSCAN THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $45.00K, a 136.84% increase year-over-year.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $1.23M, a 13566.67% increase year-over-year.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $183.00K, a 73.17% decline year-over-year.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $258.00K.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $1.72M, a 141.49% increase from fiscal 2023.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $711.00K, a 434.59% increase from fiscal 2022.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $133.00K, a 54.30% decline from fiscal 2021.
- TSCAN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $291.00K, a 1.04% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.72M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.23M 10-Q · filed 2025-11-12 | $1.69M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $183.00K 10-Q · filed 2025-08-12 | $469.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $258.00K 10-Q · filed 2025-05-06 | $968.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $711.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $9.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $682.00K 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $133.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $5.00K 10-Q · filed 2023-11-09 | $244.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $31.00K 10-Q · filed 2023-08-10 | $240.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $88.00K 10-Q · filed 2023-05-10 | $272.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $291.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $212.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $63.00K 10-Q · filed 2022-08-10 | $212.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $108.00K 10-Q · filed 2022-05-12 | $175.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $288.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $26.00K 10-Q · filed 2021-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |